Kyprolis (Carfilzomib) (Carfilzomib) — Uses, Dosage, Side Effects & Safety

Drug class: Cancer & Oncology

Overview

Kyprolis (carfilzomib) is a prescription medication used to treat adults with multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow. It is typically used in combination with other medications such as dexamethasone or lenalidomide, especially in patients who have received one or more prior therapies. Kyprolis works by blocking the action of proteasomes, which are enzyme complexes that help break down proteins in cells. By inhibiting proteasomes, Kyprolis causes cancer cells to accumulate damaged proteins, leading to cell death. This helps slow the progression of multiple myeloma. Key points for patients: Kyprolis is given as an intravenous infusion by a healthcare professional, usually in a hospital or clinic. It is important to attend all scheduled appointments and report any side effects, especially signs of infection, heart problems, or unusual bleeding.

Therapeutic uses

• Multiple Myeloma (relapsed or refractory)
• Multiple Myeloma (newly diagnosed, in combination with other agents)

Common side effects

• Fatigue
• Nausea
• Diarrhea
• Shortness of breath
• High blood pressure
• Heart problems
• Kidney problems
• Infusion-related reactions

Frequently Asked Questions about Kyprolis (Carfilzomib)

What is Kyprolis used for?

Kyprolis is used to treat adults with multiple myeloma, usually in combination with other medications, after at least one prior therapy.

How is Kyprolis administered?

Kyprolis is given as an intravenous infusion by a healthcare professional, typically in a hospital or clinic setting.

What are the most common side effects of Kyprolis?

Common side effects include fatigue, nausea, diarrhea, fever, shortness of breath, and low blood cell counts.

Can Kyprolis cause heart problems?

Yes, Kyprolis may increase the risk of serious heart problems, including heart failure and heart attack. Patients should be monitored closely for symptoms.

Is Kyprolis safe during pregnancy or breastfeeding?

Kyprolis is not recommended during pregnancy or breastfeeding due to potential harm to the baby.

What should I do if I miss a dose?

Contact your healthcare provider immediately to reschedule. Do not attempt to self-administer or double up doses.

Are there any foods or medicines I should avoid while taking Kyprolis?

Avoid live vaccines, and inform your doctor about all medicines and supplements you are taking to prevent interactions.

Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.